Distinct functions of PBRM1 and BAP1 reconcile the course of kidney cancer evolution and disease progression
Daqi Deng, Hugang Feng, Annika Fendler, Yuliia Dovga, Fiona Byrne, Charlotte Spencer, Alice C. Martin, Ángel Fernández-Sanromán, Omar Bouricha, Scott T.C. Shepherd, Hongchang Fu, Anne-Laure Cattin, Husayn Ahmed Pallikonda, Irene Lobón, Kevin Mulder, , Samra Turajlic
This study identifies distinct molecular programs in PBRM1- and BAP1-driven ccRCC, explaining their different evolutionary trajectories and clinical outcomes.
bioRxiv · May 3, 2026 · PreprintCancer Biology